Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Comparison between OCT B-Scan and En Face Imaging for the Diagnosis of Early Macular Atrophy in Age-Related Macular Degeneration
Author Affiliations & Notes
  • Omer Trivizki
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Tel Aviv, Israel
  • Yuxuan Cheng
    Bioengineering, University of Washington, Seattle, Washington, United States
  • Monika Fleckenstein
    University of Utah Health John A Moran Eye Center, Salt Lake City, Utah, United States
  • Steffen Schmitz-Valckenberg
    University of Utah Health John A Moran Eye Center, Salt Lake City, Utah, United States
  • Giovanni Gregori
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Ruikang K Wang
    Bioengineering, University of Washington, Seattle, Washington, United States
  • Philip J Rosenfeld
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Omer Trivizki TrueMed, Code C (Consultant/Contractor), PercieveBio, Code F (Financial Support); Yuxuan Cheng None; Monika Fleckenstein None; Steffen Schmitz-Valckenberg AlphaRET, Apellis, Bioeq, Katairo, Kubota Vision, Novartis, Pixium, Roche, Sparingvision, Code C (Consultant/Contractor), Bayer, Carl Zeiss MediTec, Heidelberg Engineering, Roche, Code F (Financial Support), Apellis, Heidelberg Engineering, Code R (Recipient); Giovanni Gregori Carl Zeiss Meditec, Code F (Financial Support); Ruikang Wang Carl Zeiss Meditec, Code C (Consultant/Contractor), Carl Zeiss Meditec, Colgate Palmolive Company, Estee Lauder Inc, Code F (Financial Support), US8,750,586, US8,180,134, US9,282,905, US9,759,544, US 10,354,378, US10,529,061, Code P (Patent); Philip Rosenfeld Apellis, Carl Zeiss Meditec, Ocudyne, InflammX, Regeneron, Unity Biotechnology, Boehringer-Ingelheim, Annexon, Bayer , Code C (Consultant/Contractor), Apellis, Ocudyne, InflammX , Valitor, Code O (Owner), Carl Zeiss Meditec, Code R (Recipient)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4829. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Omer Trivizki, Yuxuan Cheng, Monika Fleckenstein, Steffen Schmitz-Valckenberg, Giovanni Gregori, Ruikang K Wang, Philip J Rosenfeld; Comparison between OCT B-Scan and En Face Imaging for the Diagnosis of Early Macular Atrophy in Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4829.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the similarities between the grading of early atrophy on OCT B-scans with the grading of these lesions on en face OCT images from the same patient on the same day, we compared the gradings of complete retinal pigment epithelium and outer retinal atrophy (cRORA) and incomplete retinal pigment epithelium and outer retinal atrophy (iRORA) on B-scans with the grading of persistent choroidal hypertransmission defects (hyperTDs) on en face OCT images.

Methods : This retrospective study consisted of 19 eyes with late nonexudative AMD undergoing same day 6x6 mm macular scans using both SD-OCT (Spectralis® Heidelberg, 512x97, ART:9) and SS-OCTA (PLEX® Elite 9000, Carl Zeiss Meditec, 500x500 angio pattern) instruments. SS-OCTA and SD-OCT en face images were generated from a sub-retinal pigment epithelium slab positioned 64-400 μm below Bruch's membrane. Grading of cRORA and iRORA on SD-OCT B-scan images was performed using individual B-scans and then when looking at neighboring B-scans (+/-5) when performing the grading exercise.

Results : There was a high degree of agreement (99.6%) between the gradings of cRORA lesions and persistent hyperTDs. However, when using individual B-scans, 50% of iRORA lesions were found to be contained within persistent hyperTDs were cRORA when graded in a non-horizontal dimension. When neighboring B-scans were included in the B-scan grading, 27.4% of iRORA lesions were found to be contained within persistent hyperTDs and were cRORA when graded in a non-horizontal dimension.

Conclusions : While the horizontal B-scan diagnosis of cRORA and the en face diagnosis of persistent choroidal hyperTDs have an excellent agreement of 99.6%, the horizontal B-scan diagnosis of iRORA is frequently associated with persistent hyperTDs on en face imaging that have a non-horizontal dimension ≥ 250 µm suggesting the need to use en face images when grading cRORA or the need to include neighboring B-scans from dense raster scan patterns when grading the full extent of hyperTDs, but even after including the neighboring 5 B-scans, 27.4% of iRORA is cRORA on en face imaging.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×